# TRC105 for Liver Cancer That Has Not Responded to Sorafenib

> **NCT01375569** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 11 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatocellular Cancer
- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** TRC105

## Key facts

- **NCT ID:** NCT01375569
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-22
- **Primary completion:** 2014-02-01
- **Final completion:** 2015-12-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01375569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01375569, "TRC105 for Liver Cancer That Has Not Responded to Sorafenib". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01375569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*